We are live on
!
Find out more
SCA
STALEY CAPITAL ADVISERS Portfolio holdings
AUM
$2.36B
1-Year Est. Return
23.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.18%
1 Year Est. Return
+23.72%
3 Year Est. Return
+72.54%
5 Year Est. Return
+79.76%
10 Year Est. Return
+284.42%
AUM
$955M
AUM Growth
+$30M
(+3.2%)
Cap. Flow
+$7.76M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
40.59%
Holding
138
New
6
Increased
23
Reduced
33
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$2.38M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$2.34M |
| 3 |
Microsoft
MSFT
|
+$1.34M |
| 4 |
JPMorgan Chase
JPM
|
+$1.1M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.14M |
| 2 |
McEwen Inc
MUX
|
+$1.1M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$849K |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$486K |
| 5 |
Coca-Cola
KO
|
+$470K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.06% |
| 2 | Industrials | 10.67% |
| 3 | Healthcare | 10.09% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alcoa
AA
$11.9B
| $163K | 0.02% |
7,305
-5,410
| -43% | -$127K |
|
127
Box
BOX
$4.37B
| $145K | 0.02% |
14,000
| – | – |
|
|
FCSC
128
DELISTED
Fibrocell Science Inc.
FCSC
| $113K | 0.01% |
6,567
| – | – |
|
129
NanoViricides
NNVC
$38.8M
| $96K | 0.01% |
3,000
| – | – |
|
|
THER
130
DELISTED
THERATECHNOLOGIES INC COM
THER
| $31K | ﹤0.01% |
15,000
| – | – |
|
|
HK
131
DELISTED
Halcon Resources Corporation
HK
| $17K | ﹤0.01% |
1,044
| – | – |
|
132
MannKind Corp
MNKD
$1.21B
| $12K | ﹤0.01% |
2,000
| – | – |
|
133
ConocoPhillips
COP
$147B
| – | – |
-7,000
| Closed | -$282K |
|
|
PML
134
PIMCO Municipal Income Fund II
PML
$485M
| – | – |
-15,500
| Closed | -$205K |
|
Similar funds
EC
BJL
HFM
CC
ROIC
CIP
HAG
G
STALEY CAPITAL ADVISERS's Q2 2016 Portfolio in Review
As of Q2 2016, STALEY CAPITAL ADVISERS held 138 positions worth $955M, up 3.2% from $925M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
STALEY CAPITAL ADVISERS's Q2 2016 filing shows 6 new, 23 increased, 33 reduced and 2 closed positions. Its largest new stake was Endo International plc: 113,000 shares worth $1.76M. The largest sale was Philip Morris, an estimated $1.14M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.
- STALEY CAPITAL ADVISERS's largest Q2 2016 buy was Endo International plc: 113,000 shares worth $1.76M.
- STALEY CAPITAL ADVISERS added most to Corning in Q2 2016, an estimated $2.38M increase.
- STALEY CAPITAL ADVISERS's biggest Q2 2016 reduction was Philip Morris, cutting an estimated $1.14M.
- STALEY CAPITAL ADVISERS fully exited ConocoPhillips in Q2 2016, selling an estimated $282K.
- STALEY CAPITAL ADVISERS's ten largest holdings make up 41% of its $955M portfolio in Q2 2016.
- STALEY CAPITAL ADVISERS opened 6 new positions and closed 2 in Q2 2016.
- STALEY CAPITAL ADVISERS's portfolio value rose 3.2% quarter-over-quarter to $955M.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2016, filed 4 Aug 2016.